SYK and COVID-19: In this work, we demonstrated that SARS‐CoV‐2 RBD spike engaged Syk‐coupled CLEC2 to activate platelets, thereby contributed to thromboinflammation in COVID‐19 patients (Sung & Hsieh, 2021).